2013 American Transplant Congress
Effects of Locoregional Treatment and “Downstaging” on Long-Term Post-Liver Transplant Outcomes for Patients with Hepatocellular Carcinoma
Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Research, UNOS, Richmond, VA
IntroductionLocoregional therapy (LRT) has been used to stabilize tumor growth for patients with hepatocellular carcinoma (HCC) waiting for liver transplantation (LT). However, the long-term effects…2013 American Transplant Congress
Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 5 Years Follow-Up of the ZEUS Trial
ZEUS Study Group, Germany; Novartis Pharma, Nuremberg, Germany
Aim: To follow-up (FU) on renal function (RF), efficacy and safety after conversion to an Everolimus (EVE)/Enteric-Coated Mycophenolate Sodium (EC-MPS) regimen after cyclosporine A (CsA)…2013 American Transplant Congress
Tauroursodeoxycholic Acid Alleviate Ischemia-Reperfusion Injury in Donation after Cardiac Death Liver Transplantation
Background Donation after Cardiac Death (DCD) liver graft can provide possible and practical solutions to the organ shortage crisis, but extended warm ischemia time aggravates…2013 American Transplant Congress
Favorable Post-Transplant Survival for Liver Transplant Recipients with Treated Porto_Pulmonary Hypertension
Background: Portopulmonary hypertension (PPH) was once considered an absolute contraindication for liver transplantation (LT) because of associated high peri- and postoperative mortality rates. With evolution…2013 American Transplant Congress
Causes of Kidney Allograft Loss and Death in the United States, 2000-2010
We sought to describe causes of kidney graft failure (GF) and death with function (DWF) by time posttransplant, and whether causes of immediate GF differed…2013 American Transplant Congress
Geographic Heterogeneity in Use and Outcome of DCD Livers
Background/Aim: Donation after circulatory death (DCD) liver transplants (LTs) are increasingly performed due to organ shortage. Graft survival rates for DCD LTs are inferior to…2013 American Transplant Congress
Outcome on Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 4 Year Data of the APOLLO Trial
APOLLO Study Group, Germany; Novartis Pharma, Nuremberg, Germany
Objective: Assessment of renal function, safety and efficacy of an Everolimus (EVE) regimen after Calcineurin-Inhibitor (CNI) withdrawal in maintenance kidney allograft recipients.Methods: In an open-label,…2013 American Transplant Congress
Presence of Pre-Transplant Donor Specific Antibody (DSA) Does Not Reduce Pancreas Allograft Survival in Recipients Treated with IVIG
Department of Surgery, Multi Organ Transplant Program, Toronto General Hospital, Toronto, ON, Canada
Background: Evidence indicates that pre-transplant donor specific antibody (DSA) in kidney transplantation recipients worsens graft survival significantly. The impact of pre-transplant DSA on pancreas transplant…2013 American Transplant Congress
DNA Binding Transcription Factors STAT3, PU.1 and CEBPα Cooperate in Regulating the Expression of the Inflammatory Biomarker CCL2 in Human Hepatocytes
Washington University School of Medicine, St. Louis, MO
Background: CCL2 is a cytokine of the CC chemokine family primarily secreted by monocytes, macrophages and dendritic cells. CCL2 has been shown to be elevated…2013 American Transplant Congress
Cost Implications of New Kidney Allocation Policy
Introduction: Proposed kidney allocation changes in the US are expected to increase average survival. This system would provide first access for candidates in the top…
- « Previous Page
- 1
- …
- 150
- 151
- 152
- 153
- 154
- …
- 178
- Next Page »